Leukocyte-Associated Ig-Like Receptor 2 Protein
234€ (5 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Leukocyte-Associated Ig-Like Receptor 2 Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx261907
tested applications
SDS-PAGE
Description
LAIR2 is a recombinant protein.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | LAIR2 |
| Conjugation | Unconjugated |
| Expression | Recombinant |
| Purity | > 90% (SDS-PAGE) |
| Size 1 | 5 µg |
| Size 2 | 20 µg |
| Size 3 | 1 mg |
| Form | Liquid |
| Tested Applications | SDS-PAGE |
| Availability | Shipped within 5-10 working days. |
| Dry Ice | No |
| UniProt ID | Q6ISS4 |
| Alias | Leukocyte-associated immunoglobulin-like receptor 2,CD306,LAIR-2 |
| Background | Protein LAIR2 |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Leukocyte Associated Immunoglobulin-Like Receptor 2 (LAIR2) is a soluble immunoregulatory protein belonging to the immunoglobulin superfamily. LAIR2 functions primarily as a natural inhibitor of immune activation by competing with its membrane-bound counterpart, LAIR1, for binding to collagens present in the extracellular matrix. This competitive binding prevents LAIR1-mediated inhibitory signaling on immune cells such as T cells, natural killer (NK) cells, and dendritic cells, which are crucial for maintaining immune homeostasis and preventing excessive immune activation. LAIR2 is expressed predominantly in immune-related tissues, including the spleen, bone marrow, and lymph nodes, and its soluble nature allows it to circulate freely in the bloodstream, acting as a systemic modulator of collagen-induced immunosuppression. Dysregulated LAIR2 expression has been implicated in various pathological conditions, such as autoimmune diseases, where its elevated levels may counteract excessive immune inhibition, or in cancers, where it could interfere with tumor-induced immunosuppressive microenvironments. Therapeutically, LAIR2 has shown promise as a biomarker for immune dysregulation and as a potential agent in immunotherapy strategies aimed at mitigating immune suppression in cancers or promoting immune tolerance in autoimmune disorders. Its precise role and interactions with other immune checkpoints continue to be a subject of active research, with a focus on leveraging its properties for clinical applications in immune modulation.
Related Products
Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Protein
Recombinant Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).
Ver Producto
Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Antibody
Polyclonal Antibody to Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2).
Ver Producto
Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) ELISA Kit
Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human LAIR2 concentrations in serum, plasma, urine and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2)
Ver Producto